BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 30378503)

  • 1. Cyclosporine A Suppresses the Malignant Progression of Oral Squamous Cell Carcinoma in vitro.
    Gao L; Dong J; Zhang N; Le Z; Ren W; Li S; Li F; Song J; Wang Q; Dou Z; Park SY; Zhi K
    Anticancer Agents Med Chem; 2019; 19(2):248-255. PubMed ID: 30378503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of NLRP3 inflammasome in 5-fluorouracil resistance of oral squamous cell carcinoma.
    Feng X; Luo Q; Zhang H; Wang H; Chen W; Meng G; Chen F
    J Exp Clin Cancer Res; 2017 Jun; 36(1):81. PubMed ID: 28637493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting of cell cycle and let-7a/STAT3 pathway by niclosamide inhibits proliferation, migration and invasion in oral squamous cell carcinoma cells.
    Li X; Ding R; Han Z; Ma Z; Wang Y
    Biomed Pharmacother; 2017 Dec; 96():434-442. PubMed ID: 29031202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tigecycline exerts an antitumoral effect in oral squamous cell carcinoma.
    Ren A; Qiu Y; Cui H; Fu G
    Oral Dis; 2015 Jul; 21(5):558-64. PubMed ID: 25581076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxysophocarpine Retards the Growth and Metastasis of Oral Squamous Cell Carcinoma by Targeting the Nrf2/HO-1 Axis.
    Liu R; Peng J; Wang H; Li L; Wen X; Tan Y; Zhang L; Wan H; Chen F; Nie X
    Cell Physiol Biochem; 2018; 49(5):1717-1733. PubMed ID: 30231242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting of Survivin Pathways by YM155 Inhibits Cell Death and Invasion in Oral Squamous Cell Carcinoma Cells.
    Zhang W; Liu Y; Li YF; Yue Y; Yang X; Peng L
    Cell Physiol Biochem; 2016; 38(6):2426-37. PubMed ID: 27287458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon γ suppresses dentin sialophosphoprotein in oral squamous cell carcinoma cells resulting in antitumor effects, via modulation of the endoplasmic reticulum response.
    Gkouveris I; Nikitakis NG; Aseervatham J; Ogbureke KUE
    Int J Oncol; 2018 Dec; 53(6):2423-2432. PubMed ID: 30320380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zerumbone targets the CXCR4-RhoA and PI3K-mTOR signaling axis to reduce motility and proliferation of oral cancer cells.
    Zainal NS; Gan CP; Lau BF; Yee PS; Tiong KH; Abdul Rahman ZA; Patel V; Cheong SC
    Phytomedicine; 2018 Jan; 39():33-41. PubMed ID: 29433681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Investigation on the Therapeutic Potential of Butein, A Tretrahydroxychalcone Against Human Oral Squamous Cell Carcinoma.
    Bordoloi D; Monisha J; Roy NK; Padmavathi G; Banik K; Harsha C; Wang H; Kumar AP; Arfuso F; Kunnumakkara AB
    Asian Pac J Cancer Prev; 2019 Nov; 20(11):3437-3446. PubMed ID: 31759370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of palmatine hydrochloride mediated photodynamic therapy on oral squamous cell carcinoma.
    Qi F; Sun Y; Lv M; Qin F; Cao W; Bi L
    Photochem Photobiol Sci; 2019 Jun; 18(6):1596-1605. PubMed ID: 31099374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Operculina turpethum extract inhibits growth and proliferation by inhibiting NF-κB, COX-2 and cyclin D1 and induces apoptosis by up regulating P53 in oral cancer cells.
    Arora R; Bharti V; Gaur P; Aggarwal S; Mittal M; Das SN
    Arch Oral Biol; 2017 Aug; 80():1-9. PubMed ID: 28351666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kochia scoparia induces apoptosis of oral cancer cells in vitro and in heterotopic tumors.
    Han HY; Lee HE; Kim HJ; Jeong SH; Kim JH; Kim H; Ryu MH
    J Ethnopharmacol; 2016 Nov; 192():431-441. PubMed ID: 27616033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fisetin Modulates Human Oral Squamous Cell Carcinoma Proliferation by Blocking PAK4 Signaling Pathways.
    Li Y; Jia S; Dai W
    Drug Des Devel Ther; 2020; 14():773-782. PubMed ID: 32158195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleotide-binding oligomerization domain 2 (NOD2) activation induces apoptosis of human oral squamous cell carcinoma cells.
    Yoon HE; Ahn MY; Kwon SM; Kim DJ; Lee J; Yoon JH
    J Oral Pathol Med; 2016 Apr; 45(4):262-7. PubMed ID: 26332444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-tumor effect of the mammalian target of rapamycin inhibitor everolimus in oral squamous cell carcinoma.
    Naruse T; Yanamoto S; Yamada S; Rokutanda S; Kawakita A; Kawasaki G; Umeda M
    Pathol Oncol Res; 2015 Jul; 21(3):765-73. PubMed ID: 25682238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo anti-tumor effect of metformin as a novel therapeutic agent in human oral squamous cell carcinoma.
    Luo Q; Hu D; Hu S; Yan M; Sun Z; Chen F
    BMC Cancer; 2012 Nov; 12():517. PubMed ID: 23151022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The in vitro and in vivo antitumor effects of clotrimazole on oral squamous cell carcinoma.
    Wang J; Jia L; Kuang Z; Wu T; Hong Y; Chen X; Leung WK; Xia J; Cheng B
    PLoS One; 2014; 9(6):e98885. PubMed ID: 24892421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of Histone Deacetylase Inhibitor Sensitivity in Combination with Cyclin-Dependent Kinase Inhibition for the Treatment of Oral Squamous Cell Carcinoma.
    Zhao B; Huang Z; Qin Z; Li Y; Wang T; Wang L; Zhou W; Yu C; Wang X; Yang S; Fan Y; Xiang R
    Cell Physiol Biochem; 2019; 53(1):141-156. PubMed ID: 31237760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetylshikonin inhibits growth of oral squamous cell carcinoma by inducing apoptosis.
    Kim DJ; Lee JH; Park HR; Choi YW
    Arch Oral Biol; 2016 Oct; 70():149-157. PubMed ID: 27371806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of IFI27 inhibits cell proliferation and invasion in oral squamous cell carcinoma.
    Wang H; Qiu X; Lin S; Chen X; Wang T; Liao T
    World J Surg Oncol; 2018 Mar; 16(1):64. PubMed ID: 29580248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.